Contract facts
FederalNo full NAICS 325412 intel page yet. Browse NAICS intelligence
RADIOPHARMACEUTICALS is a federal award for National Institutes Of Health - Cc held by Cardinal Health 414, LLC. Estimated value $55.1M ($55.1M obligated). Current period of performance ends Mar 24, 2027 (potential Sep 1, 2029). Last award drew 1 bidder. Place of performance: DUBLIN, OH. Related solicitation 24-000001.
Recompete timing
PublicCurrent PoP ends Mar 24, 2027 (216 days remaining). Agencies typically plan 12–18 months ahead — at 7.1 months out, that window is already open. The buying decision is likely already in motion.
Incumbent footprint
Public recordCardinal Health 414, LLC — $77.1M obligated across 461 awards (firm-wide, all agencies) · lead buyer Department of Veterans Affairs (VA).
Related awards
Same parent · incumbentQuery this award live in SCOUT via MCP — personalized scoring, watchlists, and capture workflow across the corpus. Learn about SCOUT MCP →
Frequently asked questions
What is contract 75N90024F00001?
75N90024F00001 (Radiopharmaceuticals) is a National Institutes Of Health - Cc award with an estimated value of $55.1M, currently held by Cardinal Health 414, LLC. Figures are USASpending-sourced public-record facts plus SCOUT recompete analysis.
Which office awarded 75N90024F00001?
National Institutes Of Health - Cc awarded 75N90024F00001 to Cardinal Health 414, LLC.
Who is the incumbent on 75N90024F00001?
Cardinal Health 414, LLC is the incumbent with $77.1M across 461 related awards in SCOUT’s public footprint. The current period of performance ends Mar 24, 2027.
When does Cardinal Health 414, LLC’s 75N90024F00001 come up for recompete?
SCOUT tracks a period-of-performance end of Mar 24, 2027. Actual solicitation timing can shift with extensions, bridges, or consolidations.
Data: Showing contracts ≥ $100K from federal procurement records (FPDS-NG, SAM.gov, and related repositories), normalized by PrimeRFP SCOUT. Each row keyed by Award ID (PIID); task orders appear as independent rows.